Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Coeptis Therapeutics Holdings (COEP) Interest & Investment Income (2021 - 2022)

Coeptis Therapeutics Holdings (COEP) has 2 years of Interest & Investment Income data on record, last reported at $257.0 in Q3 2022.

  • For Q3 2022, Interest & Investment Income rose 1506.25% year-over-year to $257.0; the TTM value through Sep 2022 reached $8969.0, changed N/A, while the annual FY2021 figure was $7577.0, 529.32% up from the prior year.
  • Interest & Investment Income reached $257.0 in Q3 2022 per COEP's latest filing, up from $49.0 in the prior quarter.
  • Across five years, Interest & Investment Income topped out at $6753.0 in Q1 2022 and bottomed at -$1827.0 in Q2 2021.